OMDA Q4 2025 Earnings Call Summary

1. Key Financial Results and Metrics

Revenue Growth: Q4 revenue reached $76 million, up 58% year-over-year; full-year revenue was $260 million, a 53% increase compared to 2024.
Member Growth: Total members grew to 886,000, a 55% increase year-over-year, with 55,000 net additions in Q4 alone.
Profitability: Achieved GAAP profitability for the first time in Q4 with a net income of $5 million, compared to a loss of $8 million in Q4 2024. Full-year GAAP net loss improved to $13 million from $47 million in 2024.
Adjusted EBITDA: Positive adjusted EBITDA of $8 million in Q4 (11% margin) and $6 million for the full year (2% margin), marking a significant turnaround from losses in the previous year.
Gross Margins: Q4 GAAP gross margin was 71%, up from 67% in the prior year; adjusted gross margin reached 73%, an all-time high.

2. Strategic Updates and Business Highlights

Multi-Condition Platform: Expanded offerings to include GLP-1 prescribing and a new cholesterol program, enhancing the integrated care model for cardiometabolic conditions.
AI Integration: Launched AI-powered tools like OmadaSpark and Meal Map to improve member engagement and support, contributing to higher retention rates.
Market Position: Positioned as a leader in GLP-1 companion care, with over 150,000 members utilizing the GLP-1 Care Track, and strong growth in non-GLP-1 programs.
Customer Relationships: Established significant partnerships, adding over 5 million covered lives, with a focus on multi-condition care.

3. Forward Guidance and Outlook

2026 Revenue Guidance: Expected revenue between $312 million to $322 million, reflecting 22% growth over 2025.
Adjusted EBITDA Guidance: Projected between $7 million to $15 million for 2026, indicating continued profitability improvement.
Growth Drivers: Anticipates growth from existing business without significant contributions from new initiatives like GLP-1 prescribing or cholesterol programs initially.

4. Bad News, Challenges, or Points of Concern

Enrollment and Conversion Rates: Guidance assumes no significant improvement in enrollment conversion or engagement rates, raising concerns about potential growth deceleration.
ARPU Concerns: Average revenue per member (ARPU) is expected to remain flat, with risks of decline due to the mix of new product offerings and competitive pricing pressures.
Market Competition: Increasing competition from point solution providers and potential market saturation in the GLP-1 space could impact future growth.

5. Notable Q&A Insights

GLP-1 Pricing Impact: Management indicated that lower GLP-1 prices could increase utilization, thereby enhancing the need for Omada's support services.
Retention and Engagement: Early results from new AI tools show promising improvements in member engagement, which could positively affect long-term retention and financial performance.
Market Dynamics: There is a notable trend towards consolidation in employee benefits, favoring multi-condition platforms like Omada over single-point solutions, which could enhance customer acquisition and retention.

Overall, Omada Health demonstrated strong financial performance in 2025, achieving profitability and significant member growth while expanding its service offerings. However, the company faces challenges related to enrollment rates and competitive pressures as it looks to maintain momentum in 2026.

OMDA — Omada Health